The Globe and Mail reports in its Wednesday, Jan. 10, edition that analysts at Acumen Capital have named Calian Group one of their "Top Ideas" for 2024. The Globe's David Leeder writes that the Acumen analysts have reaffirmed their "buy" recommendation and $75 share target. Analysts on average target the shares at $73.88. The Acumen analysts say in a note: "Calian had a difficult second half of 2023 following its fiscal Q3 results that saw it miss expectations and adjust its IT and cyberscecurity operations through some restructuring efforts. The company delivered solid Q4/FY23 results, and we believe its FY24 guidance is achievable given the strength in demand in many of its key markets including defense spending, healthcare, and cybersecurity. The company's shares are trading well below historical norms and with execution of its strategy, we believe the shares are poised to recover in 2024." The Globe reported on Sept. 1 that iA Capital rated Calian Group "buy" in new coverage. It was then worth $52.87. The Globe reported on Sept. 20 that CIBC rated Calian "outperformer" in new coverage. It was then worth $51.52. The Globe reported on Nov. 30 that Acumen rated Calian "buy." It was then worth $56.33.